Angiopoietin-2-induced arterial stiffness in CKD - Wikidata - wikimedia - TriplyDB

Angiopoietin-2-induced arterial stiffness in CKD

Angiopoietin-2-induced arterial stiffness in CKD

http://www.wikidata.org/entity/Q30578820

about

Angiopoietins and diabetic nephropathy Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury.Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease.Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?The vulnerable patient with chronic kidney disease.The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation.Sclerostin, TNF-alpha and Interleukin-18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients.Therapeutic targeting of the angiopoietin-TIE pathway.Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis.The association of angiogenic factors and chronic kidney disease.

P2860

Q26747192-CD36A1CF-0A02-4DC2-97FF-6D253FAD1CF3 Q37291351-A77D520F-40AF-4C58-9D66-F959D6B93C6E Q37519213-962F1032-5025-4076-8657-091610196B29 Q38357928-DDEF2938-E1FF-4AAD-8E27-67AE08CE92DE Q38368207-3BBD1C50-91DA-469C-B901-35092335B97E Q38688341-6988F2A3-05D7-4947-BEA6-4109D3244B61 Q38955348-923359D0-0ADD-47B4-BAF7-2186416673C1 Q39321127-7D82A269-4AF6-4DD6-B4F4-E5E62F080DF0 Q47368100-6FB59020-5A28-4636-B7F5-4D0F4EE7BA6C Q55266003-2FDF0330-19DB-496D-91D4-5E220534E095

P2860

Angiopoietin-2-induced arterial stiffness in CKD

http://www.wikidata.org/entity/Q30578820

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Angiopoietin-2-induced arterial stiffness in CKD

@ast

Angiopoietin-2-induced arterial stiffness in CKD

@en

type

label

Angiopoietin-2-induced arterial stiffness in CKD

@ast

Angiopoietin-2-induced arterial stiffness in CKD

@en

prefLabel

Angiopoietin-2-induced arterial stiffness in CKD

@ast

Angiopoietin-2-induced arterial stiffness in CKD

@en

P1433

Q30578820-F6D69982-79BF-4CE5-BAF1-5F609BF9A2C7

P1476

Q30578820-78B60E12-3DDC-45C4-90F6-F9DC96A714B3

P2093

Q30578820-2FFC84E1-1C4C-411A-8CFB-DC26C0A12C6F

Q30578820-4A164FBA-67E2-432A-8BA7-9B0038FE6E6E

Q30578820-54E4F287-CA1B-4294-A553-03D8408A98DE

Q30578820-6D979279-F6CA-4F5C-8856-EA34027C6BB6

Q30578820-8832A91B-1A70-4A4E-86FB-AADB74A5A892

Q30578820-B866A714-6FDC-4E50-99AF-3DA4F4182210

Q30578820-C5CCA4A0-8A5D-4D43-9D4D-3DB74A05419D

Q30578820-E4CF7EA9-B909-4AA5-82FB-2EC503A884CC

Q30578820-E71C5B0D-A423-4473-8C1B-D75BB45528BA

Q30578820-EC4AECB2-2497-434C-BF01-2B1B29D8D148

P2860

Q30578820-01756902-BBEE-4DBC-AF30-BC762C9B0381

Q30578820-0A34C272-A799-4503-A111-FDC09FCCC7DB

Q30578820-0CA91FB5-F4F0-4017-8E61-F4A2D26082DF

Q30578820-128DC198-3701-4A72-93A9-3F0965624728

Q30578820-1A11E8D7-729F-41A0-BDAD-E3F4AC77EFCB

Q30578820-297DE732-059C-4A28-9748-1BAEE50D90DB

Q30578820-3163FBF6-534C-4791-BE3E-E8A3E3837914

Q30578820-3247AF6A-1EFD-4872-A643-37D01E2F957C

Q30578820-350A2837-23F4-45C2-A8BE-296580C4BE13

Q30578820-36CD453E-299B-43BC-9159-1777AF560F60

P304

Q30578820-4B24F4AA-7009-4133-8D4E-51C2FF2BA2B5

P31

Q30578820-57E9D7B1-6948-48C9-9CD0-1FB2B5CD71A7

P356

Q30578820-63B72581-5274-47B9-BC95-D1C3DFFF5DD1

P433

Q30578820-07C52273-BE96-4B9D-B812-5B9117071A11

P478

Q30578820-5D8A3B8F-5418-4F10-AA6E-3556C457F8BE

P50

Q30578820-271A258D-4707-420D-97E2-9E41C1EE425E

Q30578820-315D6E15-A6A7-41FE-B5F4-98F96B0DBAAE

Q30578820-B3AA3542-5139-4D8C-BC92-9FF7178C54C1

P577

Q30578820-6DD55889-C9D3-4C76-B8AD-1B24DD982475

P698

Q30578820-BD1CB550-3CCB-4800-BF02-B90BD2FBEBA8

P932

Q30578820-52DB6A57-F863-4E6A-A3A6-6C36C7E375E6

P356

P1433

Journal of the American Society of Nephrology

P1476

Angiopoietin-2-induced arterial stiffness in CKD

@en

P2093

Chih-Kang Chiang

http://www.w3.org/2001/XMLSchema#string

Fan-Chi Chang

http://www.w3.org/2001/XMLSchema#string

Ming-Hsuan Tsai

http://www.w3.org/2001/XMLSchema#string

Pei-Ying Yeh

http://www.w3.org/2001/XMLSchema#string

Szu-Yu Pan

http://www.w3.org/2001/XMLSchema#string

Tzong-Shinn Chu

http://www.w3.org/2001/XMLSchema#string

Wen-Chih Chiang

http://www.w3.org/2001/XMLSchema#string

Yi-Ting Chen

http://www.w3.org/2001/XMLSchema#string

Yu-Ting Chang

http://www.w3.org/2001/XMLSchema#string

Yung-Ming Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

Macrophage Wnt7b is critical for kidney repair and regeneration

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model

Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.

Aortic PWV in chronic kidney disease: a CRIC ancillary study.

Arterial stiffness and cardiovascular events: the Framingham Heart Study

P304

1198-1209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013050542

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Shuei-Liong Lin

P577

2014-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24511140

http://www.w3.org/2001/XMLSchema#string

P932

4033368

http://www.w3.org/2001/XMLSchema#string